Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations

v3.21.2
Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Operating expenses        
Research and development $ 7,777 $ 5,544 $ 15,798 $ 10,648
General and administrative 2,935 2,619 5,700 5,579
Total operating expenses 10,712 8,163 21,498 16,227
Loss from operations (10,712) (8,163) (21,498) (16,227)
Other income (expense):        
Interest income 30 26 55 95
Other expense 0 (2,175) 0 (2,175)
Change in fair value of warrant liabilities 5,286 (7,305) 10,852 (6,889)
Total other income (expense), net 5,316 (9,454) 10,907 (8,969)
Net loss $ (5,396) $ (17,617) $ (10,591) $ (25,196)
Basic and diluted net loss per share $ (0.14) $ (0.88) $ (0.31) $ (1.43)
Shares used in computing net loss per share 39,332,721 19,991,894 34,176,801 17,661,968